3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Sell
29
SNNUF Quote, Financials, Valuation and Earnings
Last price:
$12.21
Seasonality move
:
-2.63%
Day range:
$12.21 - $12.21
52-week range:
$11.49 - $15.70
Dividend yield:
3.07%
P/E ratio:
34.07x
P/S ratio:
1.89x
P/B ratio:
2.05x
Volume:
3.8K
Avg. volume:
1.7K
1-year change:
-9.48%
Market cap:
$10.6B
Revenue:
$5.5B
EPS (TTM):
$0.35
Analysts' Opinion
-
Consensus RatingSmith & Nephew PLC has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Smith & Nephew PLC has an estimated downside of -- from its current price of $12.21.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $12.21.
Fair Value
-
According to the consensus of 0 analysts, Smith & Nephew PLC has -- downside to fair value with a price target of -- per share.
SNNUF vs. S&P 500
-
Over the past 5 trading days, Smith & Nephew PLC has overperformed the S&P 500 by 1.08% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Smith & Nephew PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Smith & Nephew PLC has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Smith & Nephew PLC reported revenues of --.
Earnings Growth
-
Smith & Nephew PLC earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Smith & Nephew PLC reported earnings per share of --.
Enterprise value:
13.6B
EV / Invested capital:
--
Price / LTM sales:
1.89x
EV / EBIT:
28.29x
EV / Revenue:
2.40x
PEG ratio (5yr expected):
--
EV / Free cash flow:
20.53x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
13.65x
Gross Profit (TTM):
$3.9B
Return On Assets:
3.01%
Net Income Margin (TTM):
5.41%
Return On Equity:
5.85%
Return On Invested Capital:
3.68%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2013-12-31 | 2014-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $1.2B | $1.2B | |
| Gross Profit | -- | -- | -- | $882M | $940M | |
| Operating Income | -- | -- | -- | $307M | $372M | |
| EBITDA | -- | -- | -- | $332M | $353M | |
| Diluted EPS | -- | -- | -- | $0.18 | $0.18 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.3B | $4.4B | $3.8B | $3.9B | $4.5B | |
| Total Assets | $9.5B | $10.9B | $10.1B | $9.8B | $10.5B | |
| Current Liabilities | $1.5B | $2.1B | $2.1B | $1.8B | $1.8B | |
| Total Liabilities | $4.6B | $5.6B | $4.7B | $4.6B | $5.3B | |
| Total Equity | $5B | $5.3B | $5.4B | $5.2B | $5.2B | |
| Total Debt | $2.4B | $3.4B | $2.7B | $2.8B | $3.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2013-12-31 | 2014-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $321M | $302M | |
| Cash From Investing | -- | -- | -- | -$199M | $85M | |
| Cash From Financing | -- | -- | -- | -$112M | -$426M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
SNNUF
Sector
Market Cap
$10.6B
$48.9M
Price % of 52-Week High
77.77%
49.34%
Dividend Yield
3.07%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-9.49%
-30.56%
Beta (5-Year)
0.662
0.754
Dividend yield:
3.07%
Annualized payout:
$0.38
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$12.38
200-day SMA
Sell
Level
$13.37
Bollinger Bands (100)
Sell
Level
12.39 - 15.15
Chaikin Money Flow
Sell
Level
-1.4M
20-day SMA
Sell
Level
$12.35
Relative Strength Index (RSI14)
Sell
Level
43.61
ADX Line
Sell
Level
30.17
Williams %R
Neutral
Level
-64.0292
50-day SMA
Sell
Level
$12.62
MACD (12, 26)
Sell
Level
-0.05
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Sell
Level
-1.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.1164)
Buy
CA Score
(Annual)
Level (0.0618)
Buy
Beneish M-Score
(Annual)
Level (-2.6242)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.0628)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Stock Forecast FAQ
In the current month, SNNUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SNNUF average analyst price target in the past 3 months is --.
-
Where Will Smith & Nephew PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Smith & Nephew PLC share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Smith & Nephew PLC?
Analysts are divided on their view about Smith & Nephew PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Smith & Nephew PLC is a Sell and believe this share price will rise from its current level to --.
-
What Is Smith & Nephew PLC's Price Target?
The price target for Smith & Nephew PLC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SNNUF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Smith & Nephew PLC is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SNNUF?
You can purchase shares of Smith & Nephew PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Smith & Nephew PLC shares.
-
What Is The Smith & Nephew PLC Share Price Today?
Smith & Nephew PLC was last trading at $12.21 per share. This represents the most recent stock quote for Smith & Nephew PLC. Yesterday, Smith & Nephew PLC closed at $12.21 per share.
-
How To Buy Smith & Nephew PLC Stock Online?
In order to purchase Smith & Nephew PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 21.88% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 6.11% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is up 0.83% over the past day.
